Diabetes is a chronic metabolic disease characterized by lack of insulin in the body leading
to failure of blood glucose regulation. Diabetes patients usually need frequent insulin …

Success in the oral delivery of therapeutic insulin can significantly improve the quality of life
of diabetic patients who must routinely receive injections of this drug. However, oral …

Diabetes mellitus is a metabolic endocrine disease characterized by chronic hyperglycemia
with disturbances in metabolic processes, such as those related to carbohydrates, fat, and …

Diabetes mellitus is a lifelong metabolic disease that requires frequent subcutaneous
injections of insulin. However, this method of administration can be associated with patient …

Diabetes is a group of diseases characterized by hyperglycemia and originating from the
deficiency or resistance to insulin, or both. Ultimately, the most effective treatment for …

Oral insulin nanomedicines are effective tools for therapy and management of both Type I
and Type II diabetes. This review summarizes the various nanocarriers developed so far in …

Diabetes mellitus is one of the most serious public health problems in the world. Repeated
daily injections of subcutaneous insulin is the standard treatment for patients with type 1 …

For many decades, rigorous efforts have been made worldwide to develop a successful oral
insulin-delivery system, which still remains an elusive goal. However, over the past few …

Diabetic cases have increased rapidly in recent years throughout the world. Currently, for
type-1 diabetes mellitus (T1DM), multiple daily insulin (MDI) injections is the most popular …

We design novel oral glucose sensitive nanocarriers for simulating insulin release using a
modification of mesoporous silica nanoparticles (MSN) surfaces with a sensitive shell and …